White paper on multi-cancer early detection
Prevent Cancer Foundation
August 31, 2021
Can Blood Tests Really Detect Cancer Early? A 4-Year Clinical Trial Aims to Find Out
Verywell Health
October 19, 2022
Medicare multi-cancer early detection legislation introduced in Senate
Prevent Cancer Foundation
June 3, 2021
Crapo, Bennet Introduce Bipartisan Bill to Ensure Medicare Beneficiaries Receive Coverage for Cancer Detection Technologies — Supports innovation in cancer diagnostic development and Medicare coverage for access to multi-cancer diagnostics
United State Senate Committee on Finance
May 27, 2021
Prevent Cancer Foundation leads more than 300 organizations in support of the Medicare Multi-Cancer Screening Coverage Act of 2021
Prevent Cancer Foundation
March 16, 2021
Reps. Sewell, Arrington, Ruiz and Hudson Introduce Bipartisan Legislation to Ensure Access to Innovative Multi-Cancer Screening Technologies for Medicare Beneficiaries
Congresswoman Terri Sewell
March 16, 2021
On November 18, 2021, Axios hosted a conversation on innovations in care for cancer prevention and treatment, featuring National Cancer Institute Director Ned Sharpless, Rep. Terri Sewell (D-Ala.), and Jody Hoyos, President of the Prevent Cancer Foundation.
Anne Marie Lennon, M.D., Ph.D., Johns Hopkins University School of Medicine
This primer will give viewers the background necessary to understand the components of multi-cancer early detection tests and the opportunities to enhance access to screening, reduce delays in diagnosis, and improve early detection and diagnosis.
Presented at the 2021 Prevent Cancer Advocacy Workshop: A Patient-Centered Approach to Multi-Cancer Early Detection Testing on June 17, 2021.
The 2021 Prevent Cancer Foundation Advocacy Workshop was a forum for patients, providers, advocacy organizations and other stakeholders to engage in a dialogue around emerging technology in cancer prevention and control with a focus on multi-cancer early detection screening tests.
This panel was originally presented on June 2, 2021, as part of the 2021 Prevent Cancer Dialogue: Screening. Prevention. Action. Three distinguished researchers from medicine, biostatistics and economics share their work in the field of blood-based cancer screening, examining current challenges and opportunities in the field:
Moderator: Richard C. Wender, MD, Chair of the Department of Family and Community Health, Perelman School of Medicine, University of Pennsylvania.
“A Sequence of Trials for the Early Detection of Ovarian Cancer”
Steven J. Skates, PhD, Associate in Biostatistics (Medicine) in the Cancer Center, Mass General Hospital, and Associate Professor of Medicine, Harvard Medical School
“Now That We Can Walk, Are We Ready to Run? From Single-Cancer to Multi-Cancer Early Detection”
Ruth Etzioni, PhD, Professor of Public Health Sciences Division and Rosalie and Harold Rea Brown Endowed Chair, Fred Hutchinson Cancer Research Center
“Health Economics of Multi-Cancer Blood Testing”
Sue Horton, PhD, CIGI Chair of Global Health Economics and Professor of Economics, University of Waterloo
From the 2021 Prevent Cancer Dialogue
